Serial Number
99862049
Owner
Veloxis Pharmaceuticals, Inc.Attorney
Julia Anne MathesonFiling Date
Jun 3, 2026
RELSYMPLA Trademark
Serial Number: 99862049
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Julia Anne Matheson Potomac Law Group, PLLC
1717 Pennsylvania Ave., NW
Suite 1025
Washington, DC 20006
United States
Trademark Details
Filing Date
June 3, 2026
Registration Date
Not Registered
Goods & Services
Pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of physical ailments; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of for skin wounds; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of for the treatment of burns; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of cardiovascular disease and cerebrovascular disease; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of neurological disease; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of cancer; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of osteoporosis; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of infectious diseases; pharmaceutical, peptide, and biologic preparations for the treatment of rheumatism; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of fever blisters; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of autoimmune diseases; pharmaceutical, peptide, and biologic preparations for the treatment of inflammation immunology; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of organ transplant; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of pain; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of rare diseases; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of digestive diseases; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of hematologic disorders; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of kidney diseases; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment of disease with immunosuppression; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in urology; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in rheumatology; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in nephrology; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in organ transplant; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in hematology; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in orthopedic medicine; pharmaceutical, peptide, and biologic preparations and substances for the prophylaxis and treatment in pulmonology; drug delivery agents in the form of solutions, compounds, powders, and tablets that facilitate delivery of a wide range of pharmaceuticals, peptides, and biologics